Physician profile
David Montgomery
NPI 1124108808
$8,392.37
in general payments reported to CMS, 2019-2025
44 companies · $1,301 in 2025
The $1,301 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,489 · 2020: $786 · 2021: $1,379 · 2022: $1,249 · 2023: $1,133 · 2024: $1,056 · 2025: $1,301.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,414 · Education: $75.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,414.23 |
| Education | $75.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,180.98 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $907.04 | 2019-2025 | Jardiance |
| Pfizer INC. | $666.77 | 2019-2025 | |
| Amgen INC. | $491.51 | 2019-2025 | Repatha, Repatha |
| Philips North America LLC | $420.98 | 2023-2025 | (6536) Phoenix, Technical Education Mri, (Bs0) Mechanical Atherectomy |
| Novo Nordisk INC | $384.25 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Boston Scientific Corporation | $376.62 | 2020-2025 | Watchman Flx, Watchman Access System |
| E.R. Squibb & Sons, L.L.C. | $320.20 | 2019-2025 | Eliquis, Camzyos |
| Sanofi-Aventis U.S. LLC | $315.56 | 2019-2023 | |
| Cvrx, INC. | $315.31 | 2021-2024 | Barostim Neo System |
| Merck Sharp & Dohme LLC | $313.99 | 2021-2025 | Verquvo, Belsomra, Steglatro |
| Kowa Pharmaceuticals America, INC. | $305.99 | 2020-2023 | Livalo |
| Astrazeneca Pharmaceuticals LP | $288.68 | 2019-2023 | Brilinta |
| Janssen Pharmaceuticals, INC | $276.95 | 2019-2022 | |
| Esperion Therapeutics, INC. | $272.46 | 2020-2025 | Nexletol |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $212.29 | 2021-2025 | Impella |
| Medtronic, INC. | $139.68 | 2023 | Corevalve Evolut R, Venaseal |
| Amarin Pharma, INC. | $131.34 | 2019-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $131.23 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $106.53 | 2019-2021 | |
| Bridgebio Pharma, INC. | $87.39 | 2025 | Attruby |
| Alnylam Pharmaceuticals INC. | $65.06 | 2024-2025 | Amvuttra, Onpattro |
| Abbott Laboratories | $63.18 | 2021-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Itamar Medical INC | $60.15 | 2022 | |
| Gilead Sciences, INC. | $53.47 | 2019 | |
| Biotronik INC. | $52.29 | 2025 | Biomonitor |
| Exact Sciences Corporation | $49.83 | 2025 | Cologuard Collection Kit |
| Lilly USA, LLC | $41.77 | 2019-2025 | Zepbound |
| Otsuka America Pharmaceutical, INC. | $38.94 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $37.94 | 2025 | |
| Vifor Pharma, INC. | $29.42 | 2019-2020 | |
| Bard Peripheral Vascular, INC. | $28.59 | 2022 | |
| Arbor Pharmaceuticals, INC. | $26.75 | 2020-2022 | |
| Impulse Dynamics (USA) INC. | $25.29 | 2024 | Optimizer |
| Cardiva Medical, INC. | $24.00 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Lexicon Pharmaceuticals, INC. | $21.94 | 2024 | |
| Scpharmaceuticals INC. | $19.27 | 2024 | |
| Actelion Pharmaceuticals US, INC. | $19.22 | 2023 | Opsumit |
| Amryt Pharma Holdings LTD | $19.15 | 2021 | |
| Angiodynamics, INC. | $17.33 | 2023 | Venacure 1470 Pro |
| Cleerly, INC. | $16.38 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Ani Pharmaceuticals, INC. | $14.42 | 2024 | Purified Cortrophin Gel |
| Cashflow Solutions, LLC | $11.89 | 2024 | Pcd-51 731a (US) - White, Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt |
| G Medical Diagnostic Services, INC. | $10.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Montgomery listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.